Alto Neuroscience (ANRO) is up 25.0%, or 70c to $3.50.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANRO:
- Jefferies Predicts Up to ~500% Jump for These 2 ‘Strong Buy’ Stocks
- USPTO grants Alto Neuroscience patent for MDD treatment covering ALTO-300
- Promising Outlook for Alto Neuroscience with ALTO-300’s Phase IIb Success Reinforcing Buy Rating
- Alto Neuroscience announces interim analysis from ALTO-300 trial
- Alto Neuroscience files $300M mixed securities shelf
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue